psychedelics

Nova Mentis looks at potential psilocybin treatment for obesity and diabetes

People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.

0

Awakn Life Sciences starts study on ketamine treatment for gambling addiction

Toronto-based biotechnology company Awakn has a research program on ketamine-assisted psychotherapy against multiple addictions.

0

Vancouver’s Havn Life announces first psilocybin mushroom harvest in Jamaica

Vancouver biotechnology company Havn Life will export yield to UBC-based Delic Labs for quality control and testing.

0

Psychedelics researcher explains why a bad trip is a good one after all

Petter Grahl Johnstad of the University of Bergen says a bad psychedelics trip can be a way to confront personal demons.

0

Psychedelics linked to better mental health amid COVID-19 pandemic

A study in Argentina finds association between the use of psychedelic substances with positive mental health outcomes.

0

Braxia Health opens new ketamine clinic in Montreal for mental health disorders

The new Braxia Health clinic represents the company’s fourth ketamine facility in Canada.

0

Mescaline study shows high potential for mental health, low chance of addiction

Researchers from The Netherlands, U.S. and U.K. conducted a study with 452 respondents who have used mescaline.

0

BetterLife Pharma invents implant to control release of psychedelic drugs

The Vancouver-based BetterLife Pharma Inc. develops psychedelic products and delivery systems.

0

Ayahuasca brings cheer without side effects of pharmaceutical antidepressants

A new study shows that ayahuasca offers an option in dealing with depression

0